Tags

Type your tag names separated by a space and hit enter

[Renal replacement therapies in intensive care units: cost analysis].
G Ital Nefrol. 2006 May-Jun; 23 Suppl 36:S139-42.GI

Abstract

The medical treatment of intensive care unit patients represents one of the greatest costs in the health care system. Patients affected by acute renal failure account for about -10% of cases: dialysis treatment is of major importance in an economical setting. Recent studies compared continuous renal replacement therapy (CRRT) with intermittent hemodialysis (IHD). Cost comparison of the two methods showed that CRR is more expensive due to the technical device costs, while the intermittent dialysis costs depended mostly on human resources management, e.g. a longer time spent for nurse and hemodyalisis surveillance. Moreover, a higher dialysis dose, easily obtained with CRRT, could improve survival and renal function recovery leading to a reduction in hospitalization and consequently minor health care costs. These parameters, if opportunely evaluated and verified through randomized multicentric trials, could lead to an economical balance between CRRT and IHD; nephrologists, then, could choose a method out of medical and clinical more than economic reasons.

Authors+Show Affiliations

U.O. di Nefrologia e Dialisi, Ospedale San Vincenzo, Taormina (ME).No affiliation info available

Pub Type(s)

English Abstract
Journal Article
Review

Language

ita

PubMed ID

17068741

Citation

Castellino, S, and D Santoro. "[Renal Replacement Therapies in Intensive Care Units: Cost Analysis]." Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia, vol. 23 Suppl 36, 2006, pp. S139-42.
Castellino S, Santoro D. [Renal replacement therapies in intensive care units: cost analysis]. G Ital Nefrol. 2006;23 Suppl 36:S139-42.
Castellino, S., & Santoro, D. (2006). [Renal replacement therapies in intensive care units: cost analysis]. Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia, 23 Suppl 36, S139-42.
Castellino S, Santoro D. [Renal Replacement Therapies in Intensive Care Units: Cost Analysis]. G Ital Nefrol. 2006 May-Jun;23 Suppl 36:S139-42. PubMed PMID: 17068741.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Renal replacement therapies in intensive care units: cost analysis]. AU - Castellino,S, AU - Santoro,D, PY - 2006/10/28/pubmed PY - 2008/3/14/medline PY - 2006/10/28/entrez SP - S139 EP - 42 JF - Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia JO - G Ital Nefrol VL - 23 Suppl 36 N2 - The medical treatment of intensive care unit patients represents one of the greatest costs in the health care system. Patients affected by acute renal failure account for about -10% of cases: dialysis treatment is of major importance in an economical setting. Recent studies compared continuous renal replacement therapy (CRRT) with intermittent hemodialysis (IHD). Cost comparison of the two methods showed that CRR is more expensive due to the technical device costs, while the intermittent dialysis costs depended mostly on human resources management, e.g. a longer time spent for nurse and hemodyalisis surveillance. Moreover, a higher dialysis dose, easily obtained with CRRT, could improve survival and renal function recovery leading to a reduction in hospitalization and consequently minor health care costs. These parameters, if opportunely evaluated and verified through randomized multicentric trials, could lead to an economical balance between CRRT and IHD; nephrologists, then, could choose a method out of medical and clinical more than economic reasons. SN - 0393-5590 UR - https://www.unboundmedicine.com/medline/citation/17068741/[Renal_replacement_therapies_in_intensive_care_units:_cost_analysis]_ DB - PRIME DP - Unbound Medicine ER -